Recherchemedicale.com
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Tumeurs kystiques, mucineuses et séreuses
Cystadénocarcinome
Cystadénocarcinome : Questions médicales fréquentes
Diagnostic
5
Cystadénocarcinome
Biopsie
Imagerie médicale
Échographie
Tomodensitométrie
Imagerie par résonance magnétique
Marqueurs tumoraux
CA-125
CA 19-9
Diagnostic précoce
Symptômes
Cystadénocarcinome
Imagerie médicale
Cystadénocarcinome
Stadification
Symptômes
5
Symptômes
Douleur abdominale
Perte de poids
Nausées
Cystadénocarcinome
Symptômes
Symptômes
Douleurs pelviennes
Cystadénocarcinome
Cystadénocarcinome
Localisation
Symptômes
Consultation médicale
Symptômes
Cystadénocarcinome
Prévention
5
Prévention
Cystadénocarcinome
Suivi médical
Facteurs de risque
Tabagisme
Poids santé
Dépistage
Cystadénocarcinome
Prévention
Antécédents familiaux
Cancers
Facteurs de risque
Alimentation
Antioxydants
Prévention
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Cystadénocarcinome
Stadification
Chimiothérapie
Carboplatine
Paclitaxel
Radiothérapie
Cystadénocarcinome
Traitement palliatif
Essais cliniques
Thérapies ciblées
Immunothérapie
Complications
5
Complications
Propagation
Douleurs chroniques
Récidive
Cystadénocarcinome
Suivi médical
Douleur
Analgésiques
Thérapies complémentaires
Chimiothérapie
Effets secondaires
Fatigue
Qualité de vie
Complications
Cystadénocarcinome
Facteurs de risque
5
Facteurs de risque
Cystadénocarcinome
Antécédents familiaux
Mode de vie
Tabagisme
Obésité
Hormones
Cystadénocarcinome
Facteurs de risque
Prédispositions génétiques
BRCA1
BRCA2
Substances chimiques
Facteurs de risque
Cystadénocarcinome
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome : Questions médicales les plus fréquentes",
"headline": "Cystadénocarcinome : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cystadénocarcinome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-01",
"dateModified": "2024-12-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"url": "https://recherchemedicale.com/mesh/D018297",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"code": {
"@type": "MedicalCode",
"code": "D018297",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome mucineux",
"alternateName": "Cystadenocarcinoma, Mucinous",
"url": "https://recherchemedicale.com/mesh/D018282",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome mucineux",
"code": {
"@type": "MedicalCode",
"code": "D018282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.225"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome papillaire",
"alternateName": "Cystadenocarcinoma, Papillary",
"url": "https://recherchemedicale.com/mesh/D018283",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome papillaire",
"code": {
"@type": "MedicalCode",
"code": "D018283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome séreux",
"alternateName": "Cystadenocarcinoma, Serous",
"url": "https://recherchemedicale.com/mesh/D018284",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome séreux",
"code": {
"@type": "MedicalCode",
"code": "D018284",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480.240"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome",
"alternateName": "Cystadenocarcinoma",
"code": {
"@type": "MedicalCode",
"code": "D003536",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hui Liu",
"url": "https://recherchemedicale.com/author/Hui%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Ao Wang",
"url": "https://recherchemedicale.com/author/Ao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Gynecology and Obstetrics, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Yushan Ma",
"url": "https://recherchemedicale.com/author/Yushan%20Ma",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Min Sun",
"url": "https://recherchemedicale.com/author/Min%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Xiangya Hospital, Central South University Changsha, Hunan, China."
}
},
{
"@type": "Person",
"name": "Yoshifumi Iwagami",
"url": "https://recherchemedicale.com/author/Yoshifumi%20Iwagami",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cystadenocarcinoma of the gallbladder: A case report.",
"datePublished": "2022-11-17",
"url": "https://recherchemedicale.com/article/36582893",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amsu.2022.104955"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary Serous Cystadenocarcinoma of the Spleen.",
"datePublished": "2024-02-28",
"url": "https://recherchemedicale.com/article/38558745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.55165"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management of Mucinous Cystic Neoplasms of the Liver.",
"datePublished": "2023-05-23",
"url": "https://recherchemedicale.com/article/37221388",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11605-023-05709-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Cysts: Reappraisal of the Classification, Terminology, Differential Diagnosis, and Clinicopathologic Characteristics in 258 Cases.",
"datePublished": "2022-07-04",
"url": "https://recherchemedicale.com/article/35778790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PAS.0000000000001930"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report.",
"datePublished": "2023-06-05",
"url": "https://recherchemedicale.com/article/37415996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.39983"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://recherchemedicale.com/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs kystiques, mucineuses et séreuses",
"item": "https://recherchemedicale.com/mesh/D018297"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cystadénocarcinome",
"item": "https://recherchemedicale.com/mesh/D003536"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cystadénocarcinome - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cystadénocarcinome",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cystadénocarcinome",
"description": "Comment diagnostiquer un cystadénocarcinome ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nLe diagnostic précoce est-il possible ?\nQuelle est l'importance de l'imagerie ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cystadénocarcinome",
"description": "Quels sont les symptômes courants ?\nLe cystadénocarcinome cause-t-il des nausées ?\nY a-t-il des symptômes spécifiques aux femmes ?\nLes symptômes varient-ils selon l'emplacement ?\nQuand consulter un médecin pour des symptômes ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cystadénocarcinome",
"description": "Peut-on prévenir le cystadénocarcinome ?\nQuels facteurs de risque sont évitables ?\nLe dépistage précoce aide-t-il ?\nLes antécédents familiaux influencent-ils le risque ?\nY a-t-il des recommandations alimentaires ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cystadénocarcinome",
"description": "Quels traitements sont disponibles ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels médicaments sont utilisés en chimiothérapie ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements expérimentaux ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cystadénocarcinome",
"description": "Quelles complications peuvent survenir ?\nLe cystadénocarcinome peut-il récidiver ?\nComment gérer la douleur liée au cancer ?\nY a-t-il des risques liés à la chimiothérapie ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cystadénocarcinome",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque ?\nLes hormones jouent-elles un rôle ?\nY a-t-il des prédispositions génétiques ?\nL'exposition à des substances chimiques est-elle un risque ?",
"url": "https://recherchemedicale.com/mesh/D003536#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cystadénocarcinome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie, la biopsie et les marqueurs tumoraux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, le scanner et l'IRM."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "CA-125 et CA 19-9 sont souvent mesurés pour évaluer le cystadénocarcinome."
}
},
{
"@type": "Question",
"name": "Le diagnostic précoce est-il possible ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est souvent difficile en raison de symptômes non spécifiques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie aide à localiser la tumeur et à évaluer son extension."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur abdominale, ballonnements et perte de poids."
}
},
{
"@type": "Question",
"name": "Le cystadénocarcinome cause-t-il des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nausées peuvent survenir en raison de la pression sur les organes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux femmes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes peuvent ressentir des douleurs pelviennes et des irrégularités menstruelles."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent de la localisation de la tumeur, comme ovarienne ou pancréatique."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cystadénocarcinome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et maintenir un poids santé peuvent réduire certains risques."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage peut aider à détecter des anomalies, mais n'élimine pas le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancers peuvent augmenter le risque de cystadénocarcinome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour enlever la tumeur, selon son stade."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés en chimiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme le carboplatine et le paclitaxel sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée pour réduire la taille de la tumeur ou soulager la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques évaluent de nouvelles thérapies ciblées et immunothérapies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation de la maladie et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le cystadénocarcinome peut-il récidiver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive après traitement, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur liée au cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des thérapies complémentaires peuvent aider à gérer la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la chimiothérapie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut entraîner des effets secondaires comme la fatigue et les nausées."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et des antécédents familiaux de cancer."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'obésité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les hormones jouent-elles un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres hormonaux peuvent contribuer au développement de tumeurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques, comme BRCA1 et BRCA2, augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances chimiques est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de cancer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/12/2024
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Gynecology and Obstetrics, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Xiangya Hospital, Central South University Changsha, Hunan, China.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterological Surgery, Osaka International Cancer Institute.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, Osaka Police Hospital.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterological Surgery, National Hospital Organization Osaka National Hospital.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Publications dans "Cystadénocarcinome" :
2 publications dans cette catégorie
Affiliations :
From the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Urology, Toowoomba Hospital, Queensland, Australia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Department of surgery, Rabta Hospital, Tunisia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Department of surgery, Rabta Hospital, Tunisia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Department of surgery, Rabta Hospital, Tunisia.
Publications dans "Cystadénocarcinome" :
1 publication dans cette catégorie
Affiliations :
Department of surgery, Rabta Hospital, Tunisia.
Publications dans "Cystadénocarcinome" :
Cystadenoma and cystadenocarcinoma of the biliary duct remain a rare diagnosis, the localization is intrahepatic in 97% of the cases and extrahepatic in 3%of them [1]. Cystadenocarcinoma of the gallbl...
We present a 70-year-old woman, with no family or personal history, who was complaining of pain in the right hypochondrium and an altered general well-being, with no other clinical abnormalities.The i...
Cystadenocarcinoma is a rare diagnosis.There are no specific symptoms or lesions at the imaging.The confirmation is obtained on an anatomopathological study of the specimen....
Tumours of the spleen are uncommon, and most are metastases from primaries in other organs. Primary splenic malignancies are subdivided into two main groups: lymphoid and non-lymphoid. Primary splenic...
Mucinous cystic neoplasms of the liver (MCN-L) including biliary cystadenomas (BCA) and biliary cystadenocarcinomas (BCAC) are rare cystic lesions that comprise less than 5% of all liver cysts and aff...
A comprehensive review of the literature was performed using MEDLINE/Pubmed and Web of Science databases. In PubMed, the terms "biliary cystadenoma," "biliary cystadenocarcinoma," and "non parasitic h...
US imaging, CT, and MRI, as well as consideration of clinicopathological features, are required to appropriately characterize and diagnose hepatic cystic tumors. BCA are premalignant lesions and canno...
MCN-L are rare cystic liver tumors that include BCA and BCAC, which can be difficult to differentiate based on imaging alone. Surgical resection remains the mainstay of management for MCN-L with recur...
The literature on liver cysts is highly conflicting, mostly owing to definitional variations. Two hundred and fifty-eight ≥1 cm cysts evaluated pathologically using updated criteria were classifiable ...
Mucinous neoplasms are commonly seen in the ovaries and pancreas. Their occurrence in the retroperitoneum is uncommon. We present a case of a retroperitoneal mucinous cystadenocarcinoma in a 54-year-o...
Mucinous cystadenocarcinoma of the breast is a rare primary breast carcinoma having distinct clinical behavior and a favorable prognosis. It has a characteristic morphology that must be differentiated...
Giant ovarian tumors are rare in the present day due to the early diagnosis and treatment. However, owing to the large size, it can often compress the inferior vena cava and sudden decompression of it...
Cystadenocarcinoma is a malignant tumor that has undergone various classifications due to its wide variety of pathological forms since the World Health Organization (WHO) classification in 2005. We pr...
Breast mucinous cystadenocarcinoma (BMCA) is a rare tumour recently recognised as a distinct entity by the World Health Organisation Tumour Classification Series. BMCA is a triple-negative tumour that...
In this study, we used immunohistochemical staining methods to investigate TRPS1 (trichorhinophalangeal syndrome type 1) expression in BMCA and compare it to expression in ovarian and pancreatic mucin...
To our knowledge, this is the first demonstration of TRPS1 expression in BMCA patients and the first identification of a PIK3CA hotspot mutation in these tumours. These findings provide insights into ...
Although the effect of pseudogene ANXA2P2 on some tumors has been reported in a few literatures, the therapeutic potential and prognostic value of ANXA2P2 in ovarian serous cystadenocarcinoma (OV) hav...
The correlation for ANXA2P2 expression patterns to prognostic characteristics, tumor immune microenvironment, immune cell infiltration level, tumor mutation burden (TMB), tumor microsatellite instabil...
ANXA2P2 was frequently overexpressed in a variety of tumors compared with normal tissues. The correlation analysis for prognostic characteristics, tumor immune microenvironment, immune cell infiltrati...
In summary, our findings might provide a helpful foundation for prospective explorative researches, afford new strategies for the clinical treatment, deal prognosis prediction, and give new hope for O...